What do systematic reviews say?

Prostanoids vs placebo

Prostanoids showed no clear difference in cardiovascular mortality compared with placebo (low certainty).

• Prostanoids for critical limb ischaemia 2018 · Cochrane Headline outcomes only
  RR 0.81 [0.41, 1.58]
  3 studies · 1170 participants
  Low

Prostanoids vs naftidrofuryl

The review found no eligible studies for this question.

• Prostanoids for critical limb ischaemia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Prostanoids vs pentoxifylline

The review found no eligible studies for this question.

• Prostanoids for critical limb ischaemia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

PGE1 vs ATP

The review found no eligible studies for this question.

• Prostanoids for critical limb ischaemia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

PGE1 vs inositol niacinate

The review found no eligible studies for this question.

• Prostanoids for critical limb ischaemia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Iloprost vs PGE1

The review found no eligible studies for this question.

• Prostanoids for critical limb ischaemia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Clinprost vs lipo‐PGE1

• Prostanoids for critical limb ischaemia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 1 participants
  GRADE not reported